Erratum: Subgroup analysis of the AFTER I-O study: A retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma (Japanese Journal of Clinical Oncology (2021) DOI: 10.1093/jjco/hyab114)

Yoshihiko Tomita, Go Kimura, Satoshi Fukasawa, Kazuyuki Numakura, Yutaka Sugiyama, Kazutoshi Yamana, Sei Naito, Hirokazu Kaneko, Yohei Tajima, Mototsugu Oya

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Erratum: Subgroup analysis of the AFTER I-O study: A retrospective study on the efficacy and safety of subsequent molecular targeted therapy after immune-oncology therapy in Japanese patients with metastatic renal cell carcinoma (Japanese Journal of Clinical Oncology (2021) DOI: 10.1093/jjco/hyab114)'. Together they form a unique fingerprint.

Medicine & Life Sciences